Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Scientists have developed a novel technique to make production of biodegradable plastic cheaper and greener. The findings could help make the biodegradable plastic known as polylactic acid (PLA) a full-fledged alternative to cheaper traditional petroleum-based plastics. PLA is not yet considered a full alternative to traditional petroleum-based plastics, as it is costly to produce.

  • Using biochemical and bio-informatics tools, researchers developed a new method to analyze the structure of the venom toxins. Thousands of toxins hidden deep within the venom of a sea cone snail in Queensland has been discovered by Australian researchers. The discovered toxins could be a new target to develop drugs to treat pain, cancer and other diseases.  The study was published in the journal PNAS.

  • On World Population Day, Shri J P Nadda, Minister for Health & Family Welfare suggested the idea of taking up the task of population stabilisation in the country by adopting a Mission Mode approach, where focused and targeted work in taken up in those states where the figures have been high.

  • SkylineDx, a Dutch-based innovative biotechnology company specialising in the development and commercialization of genetic tests, has launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods.

    [adsense:336x280:8701650588]

  • A research group at Umeå University in Sweden has managed to capture and describe a protein structure. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications. The result of the study is published in the journal Nature Communications.

  • A new study offers clues as to why a swine flu vaccine given to 6 million people in Britain was found to have triggered narcolepsy in rare cases. Scientists believe that the Pandemrix vaccine, manufactured by GlaxoSmithKline PLC (GSK), could harm a critical portion of the brain used for regulating sleep. Pandemrix was recommended by the U.K. government during the 2009-2010 swine flu outbreak, but was withdrawn after medical records showed a growing number of narcolepsy cases among those who received the vaccine.Researchers believe that the vaccine could harm a critical portion of the brain used for regulating sleep. The vaccine caused chronic illness in about one in 55,000 recipients. The study is printed in the journal Science Transitional Medicine.

Subscribe to Pharma News